Medifast
MED
239 hedge funds and large institutions have $1.36B invested in Medifast in 2019 Q3 according to their latest regulatory filings, with 36 funds opening new positions, 83 increasing their positions, 79 reducing their positions, and 48 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
12.69% more ownership
Funds ownership: 98.09% → 110.78% (+13%)
5% more repeat investments, than reductions
Existing positions increased: 83 | Existing positions reduced: 79
5% less funds holding
Funds holding: 251 → 239 (-12)
11% less capital invested
Capital invested by funds: $1.53B → $1.36B (-$173M)
25% less first-time investments, than exits
New positions opened: 36 | Existing positions closed: 48
81% less call options, than puts
Call options by funds: $20.2M | Put options by funds: $105M
Top Buyers
Top Sellers
MED Hedge Fund Activity: Q3 2019 in Review
239 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Medifast (MED) for Q3 2019, worth a combined $1.36B — down 11% from $1.53B a quarter earlier.
Sellers outnumbered buyers: 48 funds closed out of MED and 36 opened new positions — a net loss of 12 holders — while 79 trimmed existing stakes and 83 added.
The largest buyer was Miller Value Partners, opening a new position worth an estimated $73M. The largest seller was Hoplite Capital Management, exiting entirely with an estimated $52.5M sold.
- 239 institutional investors held Medifast (MED) as of Q3 2019, down from 251 in Q2 2019.
- Funds reported $1.36B of Medifast stock for Q3 2019, down 11% quarter-over-quarter.
- 36 funds opened new Medifast positions in Q3 2019 and 48 closed out, a net change of -12 holders.
- The largest Medifast buyer in Q3 2019 was Miller Value Partners, an estimated $73M added.
- The largest Medifast seller in Q3 2019 was Hoplite Capital Management, an estimated $52.5M sold.
Based on aggregated 13F filings for Q3 2019.